|Net Assets||13.30 Mil|
- Last NAV update 5/24/2013 4:00 PM ET
|The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its net assets in common stocks of U.S. and foreign companies that have market capitalizations in the range of companies in the Russell 1000 Growth Index at the time of purchase. It invests primarily in common stocks of companies that Columbia Management Investment Advisers, LLC, the fund's investment adviser (the Investment Manager) believes have the potential for long-term growth. The fund may invest directly in foreign securities or indirectly through depositary receipts.|
- Year to date performance as of 5/23/2013 8:00 PM ET
|Fund Manager||Thomas Galvin|
|Minimum Initial Purchase||0.00|
|Minimum IRA Investment||NA|
- * Annualized returns
- Performance as of 5/23/2013 8:00 PM ET
|Net Assets||13.30 Mil||602.47 Mil|
|Avg Market Cap||37.70 Bil||38.17 Bil|
|NAME||% NET ASSETS|
|Gilead Sciences Inc||4.85%|
|FMC Technologies, Inc.||4.80%|
|Michael Kors Holdings Ltd||4.31%|
|Alexion Pharmaceuticals, Inc.||4.08%|
|Edwards Lifesciences Corporation||3.71%|
|Las Vegas Sands Corp||3.60%|
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.